{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:42:32Z","timestamp":1792539752961,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012187","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000}}],"reference-count":103,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012187.pub2","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T13:41:57Z","timestamp":1574170917000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults"],"prefix":"10.1002","volume":"2020","author":[{"given":"Tess E","family":"Cooper","sequence":"first","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R","family":"Hambleton","sequence":"additional","affiliation":[{"name":"Caribbean Institute for Health Research; Chronic Disease Research Centre; The University of the West Indies Jemotts Lane Bridgetown Barbados BB11115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir K","family":"Ballas","sequence":"additional","affiliation":[{"name":"Jefferson Medical College, Thomas Jefferson University; Cardeza Foundation for Hematologic Research, Department of Medicine; 1015 Walnut Street Philadelphia PA USA 19107-5099"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brydee A","family":"Cashmore","sequence":"additional","affiliation":[{"name":"The University of Sydney and The Children's Hospital at Westmead; Centre for Kidney Research; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"10.1002\/14651858.CD012187.pub2-BIB0001|cit1","first-page":"S149","article-title":"The use of low dose ketamine and hydromorphone for patients in sickle cell crisis","volume":"1","author":"Arambasik","year":"2013","journal-title":"Academic Emergency Medicine"},{"issue":"18","key":"10.1002\/14651858.CD012187.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1182\/blood-2009-06-227330","article-title":"A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults","volume":"114","author":"Bartolucci","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD012187.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood.V67.5.1442.1442","article-title":"A collaborative, double-blind randomized study of cetiedil citrate in sickle cell crisis","volume":"67","author":"Benjamin","year":"1986","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD012187.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/papr.12313","article-title":"Fentanyl buccal tablet: a new breakthrough pain medication in early management of severe vaso-occlusive crisis in sickle cell disease","volume":"16","author":"Franceschi","year":"2016","journal-title":"Pain Practice"},{"issue":"8","key":"10.1002\/14651858.CD012187.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0196-0644(88)80554-7","article-title":"Comparison of intramuscular analgesic activity of butorphanol and morphine in patients with sickle cell disease","volume":"17","author":"Gonzalez","year":"1988","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0007|cit6","unstructured":"Perlin E Intravenous ketorolac tromethamine enhances pain control in sickle cell vaso-occlusive crisis [abstract] 18th Annual Meeting of the National Sickle Cell Disease Program; Philadelphia, PA, USA."},{"issue":"1","key":"10.1002\/14651858.CD012187.pub2-BIB0006|cit7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajh.2830460108","article-title":"Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis","volume":"46","author":"Perlin","year":"1994","journal-title":"American Journal of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1160\/Th06-12-0718","article-title":"Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial","volume":"98","author":"Qari","year":"2007","journal-title":"Thrombosis and Haemostasis"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD012187.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1111\/acem.12115","article-title":"A randomized controlled trial of paracetamol versus morphine for the treatment of acute painful crisis of sickle cell disease","volume":"20","author":"Rehmani","year":"2013","journal-title":"Academic Emergency Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012187.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0196-0644(05)82929-4","article-title":"Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect","volume":"21","author":"Wright","year":"1992","journal-title":"Annals of Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5144\/0256-4947.1999.97","article-title":"Isoxsuprine in the treatment of sickle cell painful crises: a double-blind comparative study with narcotic analgesic","volume":"19","author":"Al-Jam'a","year":"1999","journal-title":"Annals of Saudi Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012187.pub2-BIB0012|cit12","first-page":"670","article-title":"Novel trial design to evaluate oral voxelotor for the treatment of sick cell disease: The phase 3 hemoglobin oxygen affinity modulation to inhibit sickle hemoglobin polymerization (HOPE) trial","volume":"2","author":"Ataga","year":"2018","journal-title":"HemaSphere"},{"issue":"6","key":"10.1002\/14651858.CD012187.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jpainsymman.2010.03.020","article-title":"Hydroxyurea and acute painful crises in sickle cell anemia: effects of hospital length of stay and opioid utilization during hospitalisation, outpatient acute care contacts, and at home","volume":"40","author":"Ballas","year":"2010","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"e011276","DOI":"10.1136\/bmjopen-2016-011276","article-title":"SWIM (Sickle With Ibuprofen and Morphine) randomized controlled trial fails to recruit: lessons learnt","volume":"6","author":"Cho","year":"2016","journal-title":"BMJ Open"},{"issue":"21","key":"10.1002\/14651858.CD012187.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood.V116.21.2667.2667","article-title":"Initial experience with the IMPROVE trial - a phase III analgesic trial for hospitalized sickle cell painful episodes","volume":"116","author":"Dampier","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/1740774513475850","article-title":"IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies","volume":"10","author":"Dampier","year":"2013","journal-title":"Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD012187.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.thromres.2013.08.002","article-title":"A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease","volume":"132","author":"Desai","year":"2013","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0018|cit18","unstructured":"Euctr GB An evaluation of the effectiveness of ibuprofen and morphine for acute pain in sickle cell disease - ibuprofen and morphine for acute sickle cell pain http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TriallD=EUCTR2008-0068-24-GB 2008"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0019|cit19","unstructured":"Euctr IE Sickle cell anaemia is an inherited blood disorder which results in abnormal sickle shaped red blood cells which do not fit well through small blood vessels. These blockages prevention oxygen (in blood) from reaching different parts of the body resulting in painful crisis. This study will compared the effectiveness of two types of pain medication, one given through a vein and one squirted up the nose http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TriallD=EUCTR2011-005161-20-IE 2011"},{"issue":"7","key":"10.1002\/14651858.CD012187.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archinte.1991.00400070131017","article-title":"Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department","volume":"151","author":"Gonzalez","year":"1991","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0021|cit21","unstructured":"Isrctn Patient controlled analgesia (PCA) versus continuous infusion (CI) of morphine during vaso-occlusive crisis in sickle cell disease (SCD): a randomised controlled trial http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TriallD=ISRCTN74336585 2006"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0022|cit22","unstructured":"Isrctn Use of intravenous paracetamol in combination with morphine in sickle cell disease children with vaso-occlusive crisis http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TriallD=ISRCTN34491330 2009"},{"issue":"22","key":"10.1002\/14651858.CD012187.pub2-BIB0023|cit23","first-page":"238","article-title":"Arginine therapy for vaso-occlusive pain episodes in sickle cell disease","volume":"144","author":"Morris","year":"2009","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0024|cit24","unstructured":"Nct Nebulized sub-dissociative dose ketamine at three different dosing regimens for treating acute pain in the pediatric ED https:\/\/clinicaltrials.gov\/show\/NCT03950817 2019"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0025|cit25","unstructured":"Nct Ketamine infusion for sickle cell pain crisis https:\/\/clinicaltrials.gov\/show\/NCT04005209 2019"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012187.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1182\/blood-2018-99-119720","article-title":"Consistent benefit of L-glutamine observed across patients with low, medium, and high number of crises reported in the year prior to screening-analysis from the phase 3 study of L-glutamine in sickle cell anemia","volume":"132","author":"Niihara","year":"2018","journal-title":"Blood"},{"issue":"17","key":"10.1002\/14651858.CD012187.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.286.17.2099","article-title":"Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial","volume":"286","author":"Orringer","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0028|cit28","unstructured":"Pactr A comparative analysis of parenteral opioids in the management of acute sickle cell crisis in an urban primary care centre (Korle bu Polyclinic) in Accra http:\/\/www\/who.int\/trialsearch\/Trial2.aspx?TriallD=PACTR201812917283565 2018"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0029|cit29","first-page":"S7","article-title":"Gabapentin for pain in sickle cell disease: Results of a randomized phase II clinical trial","volume":"66","author":"Puri","year":"2019","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0030|cit30","first-page":"S384","article-title":"Efficacy and tolerance of lidocaine 5% patches in neuropathic pain and vaso-occlusive sickle-cell crises pain in children: a prospective multi-centre clinical study","volume":"62","author":"Rousseau","year":"2015","journal-title":"Pediatric Blood and Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012187.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/15360288.2012.758683","article-title":"Pilot study of human recombinant hyaluronidase-enhance subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes","volume":"27","author":"Sandoval","year":"2013","journal-title":"Journal of Pain & Palliative Care Pharmacotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012187.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1016\/j.jval.2019.04.1637","article-title":"Pro3 successor study: treatment and health care resource utilization by sickle cell patients who participated in the sustain study in the United States","volume":"22","author":"Shah","year":"2019","journal-title":"Value in Health"},{"issue":"10","key":"10.1002\/14651858.CD012187.pub2-BIB0033|cit33","first-page":"E7","article-title":"Pain intensity during the initial experience with the IMPROVE trial - a phase III analgesic trial for hospitalised sickle cell painful episodes","volume":"86","author":"Smith","year":"2011","journal-title":"American Journal of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.24948","article-title":"A randomized controlled trial comparing two vaso-occlusive episdoe (VOE) protocols in sickle cell disease (SCD)","volume":"93","author":"Tanabe","year":"2018","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0036|cit35","doi-asserted-by":"crossref","unstructured":"Telen MJ Wun T McCavit TL De Castro LM Krishnamurti L Lanzkron S GMI 1070: reduction in time to resolution of vaso-occlusive crisis and decreased opioid use in a prospective, randomized, multi-centre double blind, adaptive phase 2 study in sickle cell disease Blood 2013 21","DOI":"10.1182\/blood.V122.21.776.776"},{"issue":"17","key":"10.1002\/14651858.CD012187.pub2-BIB0035|cit36","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2014-583351","article-title":"Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use","volume":"125","author":"Telen","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD012187.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajem.2009.01.016","article-title":"Efficacy of tramadol vs meperidine in vasoocclusive sickle cell crisis","volume":"28","author":"Uzun","year":"2010","journal-title":"American Journal of Emergency Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012187.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ajh.20944","article-title":"Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial","volume":"82","author":"Beers","year":"2007","journal-title":"American Journal of Hematology"},{"issue":"21","key":"10.1002\/14651858.CD012187.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood.V122.21.775.775","article-title":"Effects of GMI-1070, a pan-selection inhibitor, on pain intensity and opioid utilization in sickle cell disease","volume":"122","author":"Castro","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD012187.pub2-BIB0040|cit40","first-page":"254","article-title":"Treatment of sickle cell pain crisis. A clinical trial of diflunisal","volume":"25","author":"Perlin","year":"1988","journal-title":"Clinical Trials Journal"},{"issue":"4","key":"10.1002\/14651858.CD012187.pub2-BIB0041|cit41","first-page":"320","article-title":"Double-blind randomised clinical trial of pentoxiphyllin in vaso-occlusive sickle cell crisis","volume":"41","author":"Teuscher","year":"1989","journal-title":"Tropical & Geographical Medicine"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0042|cit42","unstructured":"IRCT2016072511956N6 To relieve crisis pain in sickle cell anemia patients http:\/\/apps.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT2016072511956N6 (accessed September 2019)"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0043|cit43","unstructured":"NCT03431285 Ketamine for acute painful crisis in sickle cell disease patients clinicaltrials.gov\/ct2\/show\/NCT03431285"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0044|cit44","unstructured":"NCT03978156 Dronabinol for pain and inflammation in adults living with sickle cell disease https:\/\/clinicaltrials.gov\/show\/NCT03978156 (accessed September 2019) 2019"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006111.pub2","article-title":"Piracetam for reducing the incidence of painful sickle cell disease crises","author":"Al Hajeri","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012187.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.hoc.2005.07.008","article-title":"Pain management of sickle cell disease","volume":"19","author":"Ballas","year":"2005","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"1","key":"10.1002\/14651858.CD012187.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1182\/asheducation-2007.1.97","article-title":"Current issues in sickle cell pain and its management","volume":"2007","author":"Ballas","year":"2007","journal-title":"Hematology"},{"issue":"8292","key":"10.1002\/14651858.CD012187.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(82)90320-8","article-title":"Medroxyprogesterone acetate and homozygous sickle-cell disease","volume":"2","author":"Ceulaer","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00062752-200203000-00005","article-title":"Sickle cell disease in Africa","volume":"9","author":"Diallo","year":"2002","journal-title":"Current Opinion in Hematology"},{"issue":"4","key":"10.1002\/14651858.CD012187.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003350.pub3","article-title":"Pain management for sickle cell disease in children and adults","author":"Dunlop","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"25","key":"10.1002\/14651858.CD012187.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"e4063","DOI":"10.1136\/bmj.e4063","article-title":"Management of an acute painful sickle cell episode in hospital: summary of NICE guidance","volume":"344","author":"Gillis","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0056|cit56","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"Making an overall rating of the confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD012187.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archinte.1910.00050330050003","article-title":"Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia","volume":"5","author":"Herrick","year":"1910","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0060|cit60","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0061|cit61","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD012187.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010849.pub2","article-title":"Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease","author":"Hussein","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0065|cit65","first-page":"756","article-title":"Hematologic disorders","volume-title":"Current Pediatric Diagnosis and Treatment","author":"Lane","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0066|cit66","first-page":"8","article-title":"Updated mechanisms of sickle cell disease-associated chronic pain","volume":"2","author":"Lutz","year":"2015","journal-title":"Translational Perioperative and Pain Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012187.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006786.pub2","article-title":"Interventions for treating painful sickle cell crisis during pregnancy","author":"Mart\u00ed-Carvajal","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0068|cit68","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"7","key":"10.1002\/14651858.CD012187.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0070|cit70","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012187.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012187.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012187.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0075|cit75","unstructured":"National Screening Committee for Sickle Cell Disease and Thalassaemia NHS Sickle Cell and Thalassaemia Screening Programme, 2006 www.gov.uk\/topic\/population-screening-programmes\/sickle-cell-thalassaemia"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0076|cit76","unstructured":"National Institute of Health and Care Excellence (NICE) Guidance - sickle cell acute painful episode, 2015 (accessed 7 September 2015)"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0077|cit77","unstructured":"National Institutes of Health Evidence-based management of sickle cell disease: expert panel report, 2014 www.nhlbi.nih.gov\/guidelines"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0078|cit78","unstructured":"National Heart Lung and Blood Institute Sickle cell disease, 2015 www.nhlbi.nih.gov\/health\/health-topics\/topics\/sca\/atrisk"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012187.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012187.pub2-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005406.pub4","article-title":"Fluid replacement therapy for acute episodes of pain in people with sickle cell disease","author":"Okomo","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012187.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/014107680209500909","article-title":"Management of pain in sickle-cell disease","volume":"95","author":"Okpala","year":"2002","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"9861","key":"10.1002\/14651858.CD012187.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"issue":"23","key":"10.1002\/14651858.CD012187.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"10.1002\/14651858.CD012187.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD012187.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193","article-title":"Guidelines for the management of the acute painful crisis in sickle cell disease","volume":"120","author":"Rees","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0087|cit87","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD012187.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1037\/a0013628","article-title":"Opioids and the treatment of chronic pain: controversies, current status, and future directions","volume":"16","author":"Rosenblum","year":"2008","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012187.pub2-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009191.pub2","article-title":"Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease","author":"Sasongko","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012187.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5144\/0256-4947.1994.237","article-title":"The geography of sickle-cell disease: opportunity for understanding its diversity","volume":"14","author":"Serjeant","year":"1994","journal-title":"Annals of Saudi Medicine"},{"issue":"9442","key":"10.1002\/14651858.CD012187.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD012187.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1553-2712.2012.01330.x","article-title":"Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management","volume":"9","author":"Tanabe","year":"2012","journal-title":"Academic Emergency Medicine"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/bjh.12879","article-title":"Management of the acute painful crisis in sickle cell disease - a re-evaluation of the use of opioids in adult patients","volume":"166","author":"Telfer","year":"2014","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0094|cit94","article-title":"Classification of pain","volume-title":"Pain management: a practical guide for clinicians","author":"Thienhaus","year":"2002"},{"issue":"10","key":"10.1002\/14651858.CD012187.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PloS One"},{"issue":"2S","key":"10.1002\/14651858.CD012187.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician Journal"},{"issue":"5","key":"10.1002\/14651858.CD012187.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0735-6757(95)90163-9","article-title":"Health professional perceptions of opioid depended among patients with pain","volume":"13","author":"Waldrop","year":"1995","journal-title":"American Journal of Emergency Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012187.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1590\/S0042-96862001000800005","article-title":"Inherited haemoglobin disorders: an increasing global health problem","volume":"79","author":"Weatherall","year":"2001","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0099|cit99","first-page":"663","article-title":"Inherited disorders of hemoglobin","volume-title":"Disease Control Priorities in Developing Countries","author":"Weatherall","year":"2006"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0100|cit100","unstructured":"World Health Organization Sickle-cell disease: a strategy for the WHO African region 2010 www.afro.who.int\/en\/sixtieth-session.html"},{"key":"10.1002\/14651858.CD012187.pub2-BIB0101|cit101","volume-title":"Sickle-cell disease and other haemoglobin disorders: fact sheet N\u00b0308","author":"World Health Organization","year":"2011"},{"issue":"3","key":"10.1002\/14651858.CD012187.pub2-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005452","article-title":"Gabapentin for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012187.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012187.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T11:33:30Z","timestamp":1672486410000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012187.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":103,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012187.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]}}}